Cunningham, Richard Anthony has filed 3 insider transactions across 1 company since October 2023.
Most recent transaction: a grant/award of 316352 shares of Anebulo Pharmaceuticals, Inc. ($ANEB) on April 04, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 4, 2025 | Anebulo Pharmaceuticals, Inc. | $ANEB | Cunningham, Richard Anthony | Chief Executive Officer | A | Stock Option (right to buy) | 316352 | $0.00 | 316,352.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2024 | Anebulo Pharmaceuticals, Inc. | $ANEB | Cunningham, Richard Anthony | Chief Executive Officer | A | Stock Option (right to buy) | 254433 | $0.00 | 254,433.0000 | 0 | 9999.99% | 0.00% |
| Oct. 6, 2023 | Anebulo Pharmaceuticals, Inc. | $ANEB | Cunningham, Richard Anthony | Chief Executive Officer | A | Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |